![The mechanism of action of rivaroxaban – an oral, direct Factor Xa inhibitor – compared with other anticoagulants - ScienceDirect The mechanism of action of rivaroxaban – an oral, direct Factor Xa inhibitor – compared with other anticoagulants - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0049384810004810-gr1.jpg)
The mechanism of action of rivaroxaban – an oral, direct Factor Xa inhibitor – compared with other anticoagulants - ScienceDirect
![Practical Considerations for the Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation - Zachary Stacy, Sara Richter, 2017 Practical Considerations for the Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation - Zachary Stacy, Sara Richter, 2017](https://journals.sagepub.com/cms/10.1177/1076029616634886/asset/images/large/10.1177_1076029616634886-fig1.jpeg)
Practical Considerations for the Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation - Zachary Stacy, Sara Richter, 2017
![Dabigatran: Review of Pharmacology and Management of Bleeding Complications of This Novel Oral Anticoagulant | SpringerLink Dabigatran: Review of Pharmacology and Management of Bleeding Complications of This Novel Oral Anticoagulant | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13181-011-0178-y/MediaObjects/13181_2011_178_Fig1_HTML.gif)
Dabigatran: Review of Pharmacology and Management of Bleeding Complications of This Novel Oral Anticoagulant | SpringerLink
![Frontiers | Direct oral anticoagulants in pediatric venous thromboembolism: Review of approved products rivaroxaban and dabigatran Frontiers | Direct oral anticoagulants in pediatric venous thromboembolism: Review of approved products rivaroxaban and dabigatran](https://www.frontiersin.org/files/Articles/1005098/fped-10-1005098-HTML/image_m/fped-10-1005098-g001.jpg)